Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE

(ABBV)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo AbbVie
AbbVie specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease.

Sales are distributed geographically as follows: the United States (65.7%), Japan (4.9%), Germany (3.9%), the United Kingdom (2.6%), France (2.4%), Canada (2.2%) , Italy (2%), Spain (1.9%), the Netherlands (1.1%), Brazil (1.1%), and other (12.2%).

Number of employees : 30 000 people.
Sales per Businesses
20172018Delta
USD (in Million)%USD (in Million)%
HUMIRA18,42765.3%19,93660.9% +8.19%
IMBRUVICA2,5739.1%3,59011% +39.53%
HCV1,2744.5%---
All Other998.003.5%319.001% -68.04%
Creon831.002.9%928.002.8% +11.67%
Lupron829.002.9%892.002.7% +7.6%
Synthroid781.002.8%776.002.4% -0.64%
Synagis738.002.6%726.002.2% -1.63%
AndroGel577.002%469.001.4% -18.72%
Kaletra423.001.5%336.001% -20.57%
Sevoflurane410.001.5%391.001.2% -4.63%
Duodopa355.001.3%430.001.3% +21.13%
MAVYRET--3,43810.5%-
VENCLEXTA--344.001.1%-
VIEKIRA--178.000.5%-
Sales per Regions
20172018Delta
USD (in Million)%USD (in Million)%
United States18,25164.7%21,52465.7% +17.93%
All Other Countries4,08014.5%4,01312.3% -1.64%
Germany1,1574.1%1,2923.9% +11.67%
United Kingdom807.002.9%855.002.6% +5.95%
Japan764.002.7%1,5914.9% +108.25%
France730.002.6%783.002.4% +7.26%
Canada659.002.3%730.002.2% +10.77%
Spain521.001.8%611.001.9% +17.27%
Italy475.001.7%652.002% +37.26%
Brazil410.001.5%350.001.1% -14.63%
Netherlands362.001.3%352.001.1% -2.76%
Managers
NameAgeSinceTitle
Richard Gonzalez642013Chairman & Chief Executive Officer
Michael Severino532018Vice Chairman & President
Azita Saleki-Gerhardt542018Executive Vice President-Operations
Robert A. Michael482018Chief Financial Officer & Senior Vice President
Carlos Alban562018Vice Chairman & Chief Commercial Officer
Robert J. Alpern, Dr.672013Independent Director
Roxanne Austin572013Independent Director
William H. L. Burnside662013Independent Director
Edward Michael Liddy722013Independent Director
Edward J. Rapp602013Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 1,781,468,629 1,477,451,374 82.9% 302,647,520 17.0% 82.9%
Shareholders
NameEquities%
The Vanguard Group, Inc. 119,629,462 8.09%
Capital Research & Management Co. (Global Investors) 94,861,327 6.42%
SSgA Funds Management, Inc. 68,783,527 4.65%
BlackRock Fund Advisors 36,874,996 2.49%
Fidelity Management & Research Co. 33,981,940 2.30%
Geode Capital Management LLC 23,746,994 1.61%
T. Rowe Price Associates, Inc. (Investment Management) 19,778,555 1.34%
Northern Trust Investments, Inc.(Investment Management) 19,630,634 1.33%
Orbis Investment Management Ltd. 17,059,987 1.15%
Norges Bank Investment Management 14,106,418 0.95%
Markets and indexes
- NYSE
- Main Market
- SP 100 / SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  ABBV.N
- Datastream Code :  
Company contact information
AbbVie
1 Road North Waukegan
IL 60064 North Chicago, Illinois
États-Unis (les)

Phone : +1 847 932 7900
Fax : +1
Internet : http://www.abbvie.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of AbbVie
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ABBVIE-5.65%128 628
JOHNSON & JOHNSON8.78%369 462
ROCHE HOLDING AG25.45%263 079
MERCK AND COMPANY16.28%226 211
PFIZER-12.28%211 902
NOVARTIS22.87%208 547
BRISTOL-MYERS SQUIBB COMPANY14.43%140 534
AMGEN20.09%138 902
NOVO NORDISK AS28.89%133 610
ASTRAZENECA23.58%124 877
SANOFI10.44%115 690
ELI LILLY AND COMPANY3.50%114 870
GLAXOSMITHKLINE15.97%112 257
BAYER AG14.23%75 098
TAKEDA PHARMACEUTICAL COMPANY LIMITED21.13%62 841
ALLERGAN PLC39.44%61 181
JIANGSU HENGRUI MEDICINE CO., LTD.65.12%54 523
CHUGAI PHARMACEUTICAL CO., LTD.59.30%49 581
DAIICHI SANKYO COMPANY, LIMITED106.69%42 195
ASTELLAS PHARMA INC.36.21%32 397
EISAI CO., LTD.-0.55%21 738